Intermittent preventive antimalarial treatment in infancy
Your July 26 Editorial1 endorses the findings of a report fromthe US Institute of Medicine (IOM)' on intermittent preventive treatment with sulfadoxinepyrimethamine in infancy (IPTi-SP).The IOM committee supported scaling up of IPTi-SP implementation in structured programmes.
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2008-10, Vol.372 (9647), p.1383-1384 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1384 |
|---|---|
| container_issue | 9647 |
| container_start_page | 1383 |
| container_title | The Lancet (British edition) |
| container_volume | 372 |
| creator | Anon |
| description | Your July 26 Editorial1 endorses the findings of a report fromthe US Institute of Medicine (IOM)' on intermittent preventive treatment with sulfadoxinepyrimethamine in infancy (IPTi-SP).The IOM committee supported scaling up of IPTi-SP implementation in structured programmes. |
| doi_str_mv | 10.1016/S0140-6736(08)61583-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20062836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673608615834</els_id><sourcerecordid>1586835691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-fd48ed05ca55b4fa8de8c17398068398117d64e3a118f5c005674f2c725ef8ee3</originalsourceid><addsrcrecordid>eNqFkE1LJDEQhoOsrLO6P2GXYQ-ye2it6nx0-qKI6CoIHlTwFmK6GqL9MSaZgfn3Zj5Q8CKEVA5PvZV6GPuFcISA6vgOUEChKq7-gv6nUGpeiB02QVGJQorq8RubvCN77EeMzwAgFMjvbA91LfIbJ6y-HhKF3qdEQ5rOAi1y9Qua2lx629ngbTdNgWzqV4Qf8mnt4JYHbLe1XaSf27rPHi4v7s-vipvb_9fnZzeFkyVPRdsITQ1IZ6V8Eq3VDWmHFa81KJ1vxKpRgrhF1K10AFJVoi1dVUpqNRHfZ4eb3FkYX-cUk-l9dNR1dqBxHk0JoErNVQb_fAKfx3kY8t8M1jVw5AgZkhvIhTHGQK2ZhbxnWBoEsxJr1mLNypoBbdZijch9v7fh86eemo-urckMnG4Ayi4WnoKJztPgqPGBXDLN6L8ccfIpwXV-8M52L7Sk-LGMiaWBTcgqA_Q6QfA3fpOb7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199031310</pqid></control><display><type>article</type><title>Intermittent preventive antimalarial treatment in infancy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Anon</creator><creatorcontrib>Anon ; WHO IPTi Technical Expert Group</creatorcontrib><description>Your July 26 Editorial1 endorses the findings of a report fromthe US Institute of Medicine (IOM)' on intermittent preventive treatment with sulfadoxinepyrimethamine in infancy (IPTi-SP).The IOM committee supported scaling up of IPTi-SP implementation in structured programmes.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(08)61583-4</identifier><identifier>PMID: 18940461</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antimalarials - administration & dosage ; Antimalarials - adverse effects ; Drug Administration Schedule ; Drug Combinations ; Humans ; Infant ; Internal Medicine ; Malaria ; Malaria - mortality ; Malaria - prevention & control ; Medical research ; Pyrimethamine - administration & dosage ; Pyrimethamine - adverse effects ; Studies ; Sulfadoxine - administration & dosage ; Sulfadoxine - adverse effects ; Treatment Failure</subject><ispartof>The Lancet (British edition), 2008-10, Vol.372 (9647), p.1383-1384</ispartof><rights>Elsevier Ltd</rights><rights>2008 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Oct 18-Oct 24, 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-fd48ed05ca55b4fa8de8c17398068398117d64e3a118f5c005674f2c725ef8ee3</citedby><cites>FETCH-LOGICAL-c523t-fd48ed05ca55b4fa8de8c17398068398117d64e3a118f5c005674f2c725ef8ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/199031310?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18940461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anon</creatorcontrib><creatorcontrib>WHO IPTi Technical Expert Group</creatorcontrib><title>Intermittent preventive antimalarial treatment in infancy</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Your July 26 Editorial1 endorses the findings of a report fromthe US Institute of Medicine (IOM)' on intermittent preventive treatment with sulfadoxinepyrimethamine in infancy (IPTi-SP).The IOM committee supported scaling up of IPTi-SP implementation in structured programmes.</description><subject>Antimalarials - administration & dosage</subject><subject>Antimalarials - adverse effects</subject><subject>Drug Administration Schedule</subject><subject>Drug Combinations</subject><subject>Humans</subject><subject>Infant</subject><subject>Internal Medicine</subject><subject>Malaria</subject><subject>Malaria - mortality</subject><subject>Malaria - prevention & control</subject><subject>Medical research</subject><subject>Pyrimethamine - administration & dosage</subject><subject>Pyrimethamine - adverse effects</subject><subject>Studies</subject><subject>Sulfadoxine - administration & dosage</subject><subject>Sulfadoxine - adverse effects</subject><subject>Treatment Failure</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkE1LJDEQhoOsrLO6P2GXYQ-ye2it6nx0-qKI6CoIHlTwFmK6GqL9MSaZgfn3Zj5Q8CKEVA5PvZV6GPuFcISA6vgOUEChKq7-gv6nUGpeiB02QVGJQorq8RubvCN77EeMzwAgFMjvbA91LfIbJ6y-HhKF3qdEQ5rOAi1y9Qua2lx629ngbTdNgWzqV4Qf8mnt4JYHbLe1XaSf27rPHi4v7s-vipvb_9fnZzeFkyVPRdsITQ1IZ6V8Eq3VDWmHFa81KJ1vxKpRgrhF1K10AFJVoi1dVUpqNRHfZ4eb3FkYX-cUk-l9dNR1dqBxHk0JoErNVQb_fAKfx3kY8t8M1jVw5AgZkhvIhTHGQK2ZhbxnWBoEsxJr1mLNypoBbdZijch9v7fh86eemo-urckMnG4Ayi4WnoKJztPgqPGBXDLN6L8ccfIpwXV-8M52L7Sk-LGMiaWBTcgqA_Q6QfA3fpOb7A</recordid><startdate>20081018</startdate><enddate>20081018</enddate><creator>Anon</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20081018</creationdate><title>Intermittent preventive antimalarial treatment in infancy</title><author>Anon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-fd48ed05ca55b4fa8de8c17398068398117d64e3a118f5c005674f2c725ef8ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antimalarials - administration & dosage</topic><topic>Antimalarials - adverse effects</topic><topic>Drug Administration Schedule</topic><topic>Drug Combinations</topic><topic>Humans</topic><topic>Infant</topic><topic>Internal Medicine</topic><topic>Malaria</topic><topic>Malaria - mortality</topic><topic>Malaria - prevention & control</topic><topic>Medical research</topic><topic>Pyrimethamine - administration & dosage</topic><topic>Pyrimethamine - adverse effects</topic><topic>Studies</topic><topic>Sulfadoxine - administration & dosage</topic><topic>Sulfadoxine - adverse effects</topic><topic>Treatment Failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anon</creatorcontrib><creatorcontrib>WHO IPTi Technical Expert Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anon</au><aucorp>WHO IPTi Technical Expert Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intermittent preventive antimalarial treatment in infancy</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2008-10-18</date><risdate>2008</risdate><volume>372</volume><issue>9647</issue><spage>1383</spage><epage>1384</epage><pages>1383-1384</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Your July 26 Editorial1 endorses the findings of a report fromthe US Institute of Medicine (IOM)' on intermittent preventive treatment with sulfadoxinepyrimethamine in infancy (IPTi-SP).The IOM committee supported scaling up of IPTi-SP implementation in structured programmes.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>18940461</pmid><doi>10.1016/S0140-6736(08)61583-4</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2008-10, Vol.372 (9647), p.1383-1384 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_20062836 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
| subjects | Antimalarials - administration & dosage Antimalarials - adverse effects Drug Administration Schedule Drug Combinations Humans Infant Internal Medicine Malaria Malaria - mortality Malaria - prevention & control Medical research Pyrimethamine - administration & dosage Pyrimethamine - adverse effects Studies Sulfadoxine - administration & dosage Sulfadoxine - adverse effects Treatment Failure |
| title | Intermittent preventive antimalarial treatment in infancy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A36%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intermittent%20preventive%20antimalarial%20treatment%20in%20infancy&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Anon&rft.aucorp=WHO%20IPTi%20Technical%20Expert%20Group&rft.date=2008-10-18&rft.volume=372&rft.issue=9647&rft.spage=1383&rft.epage=1384&rft.pages=1383-1384&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(08)61583-4&rft_dat=%3Cproquest_cross%3E1586835691%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199031310&rft_id=info:pmid/18940461&rft_els_id=S0140673608615834&rfr_iscdi=true |